XML 35 R23.htm IDEA: XBRL DOCUMENT v3.25.2
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following represents assets and liabilities measured at fair value on a recurring basis by the Company (in thousands):
June 30, 2025Fair ValueLevel 1Level 2Level 3
Assets:
Money market funds$14,979 $14,979 $— $— 
Investment in iECURE744 — — 744 
Assets held for sale140 — — 140 
$15,863 $14,979 $— $884 
Liabilities:
Final payment fee$200 $— $200 $— 
Warrant liability2,847 — — 2,847 
$3,047 $— $200 $2,847 
December 31, 2024Fair ValueLevel 1Level 2Level 3
Assets:
Money market funds$14,687 $14,687 $— $— 
Investment in iECURE3,206 — — 3,206 
Imugene Marketable Securities413 413 — — 
Assets held for sale169 — — 169 
$18,475 $15,100 $— $3,375 
Liabilities:
Final payment fee$194 $— $194 $— 
Warrant Liability2,796 — — 2,796 
$2,990 $— $194 $2,796 
Summary of Financial Assets Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs
The following represents a reconciliation of assets measured and carried at fair value on a recurring basis with the use of significant unobservable inputs (Level 3) for the six months ended June 30, 2025 (in thousands). The warrant reconciliation is disclosed in Note 13, Warrants:
Investment in iECUREAssets held for sale
Balance December 31, 2024$3,206 $169 
(Loss) gain from changes in fair value included in earnings(2,462)
Assets sold— (4)
Write-offs— (26)
Balance June 30, 2025$744 $140